Effectiveness and safety of ustekinumab in Crohn's disease: short and long-term results of a multi-refractory cohort

被引：0
|
作者：
Aparicio-Serrano, A. [1 ]
Zamora Olaya, J. M. [1 ]
Ortiz Chimbo, D. S. [1 ]
Rodriguez Tirado, M. I. [1 ]
Gomez Perez, A. [1 ]
Soto Escribano, P. [1 ]
Marin Pedrosa, S. [1 ]
Iglesias Flores, E. [1 ]
Benitez, J. M. [1 ]
机构：
[1] Reina Sofia Univ Hosp, Gastroenterol & Hepatol, Cordoba, Spain
来源：
JOURNAL OF CROHNS & COLITIS | 2022年 / 16卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
P334
引用
收藏
页码：I351 / I352
页数：2
相关论文
共 50 条
  • [1] Effectiveness and safety of ustekinumab in Crohn's disease: short and long-term results of a multi-refractory cohort
    Aparicio-Serrano, A.
    Zamora Olaya, J. M.
    Ortiz Chimbo, D. S.
    Rodriguez Tirado, M. I.
    Gomez Perez, A.
    Soto Escribano, P.
    Marin Pedrosa, S.
    Iglesias Flores, E.
    Benitez, J. M.
    JOURNAL OF CROHNS & COLITIS, 2022, 16 : I351 - I352
  • [2] Long-term effectiveness and safety of ustekinumab in Crohn's disease: a prospective cohort study
    Thomas, Pepijn W. A.
    van Caem, Mark
    West, Rachel L.
    Russel, Maurice G. V. M.
    Jansen, Jeroen M.
    Romkens, Tessa E. H.
    Hoentjen, Frank
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2023, 35 (03) : 261 - 269
  • [3] Effectiveness of swapping to ustekinumab after vedolizumab failure in patients with multi-refractory Crohn?s disease
    Melotti, Laura
    Dussias, Nikolas Konstantine
    Salice, Marco
    Calabrese, Carlo
    Baldoni, Monia
    Scaioli, Eleonora
    Belluzzi, Andrea
    Mazzotta, Elena
    Gionchetti, Paolo
    Rizzello, Fernando
    DIGESTIVE AND LIVER DISEASE, 2023, 55 (02) : 230 - 234
  • [4] Long-Term Effectiveness and Safety of Ustekinumab in Crohn's Disease: Results from a Large Real-Life Cohort Study
    Mocci, Giammarco
    Tursi, Antonio
    Scaldaferri, Franco
    Napolitano, Daniele
    Pugliese, Daniela
    Capobianco, Ivan
    Bartocci, Bianca
    Blasi, Valentina
    Savarino, Edoardo V.
    Maniero, Daria
    Redavid, Carlo
    Lorenzon, Greta
    Cuomo, Antonio
    Donnarumma, Laura
    Gravina, Antonietta Gerarda
    Pellegrino, Raffaele
    Bodini, Giorgia
    Pasta, Andrea
    Marzo, Manuela
    Serio, Mariaelena
    Scarcelli, Antonella
    Rodino, Stefano
    Sebkova, Ladislava
    Maconi, Giovanni
    Cataletti, Giovanni
    Luppino, Ileana
    Checchin, Davide
    Ferronato, Antonio
    Gaiani, Federica
    Kayali, Stefano
    Felice, Carla
    Pranzo, Giuseppe
    Catarella, Domenico
    D'Agostino, Dario
    Di Bartolo, Elisabetta
    Lombardi, Giovanni
    Patturelli, Marta
    Bendia, Emanuele
    Bolognini, Laura
    Balducci, Daniele
    Quatraccioni, Claudia
    Martini, Francesco
    Mucherino, Caterina
    D'Antonio, Elvira
    Montesano, Laura
    Vespere, Giuliana
    Sedda, Silvia
    D'Onofrio, Vittorio
    De Luca, Leonardo
    Spagnuolo, Rocco
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (23)
  • [5] Ustekinumab efficacy and safety in mucocutaneous multi-refractory Behcet's disease
    Lopalco, G.
    Fabiani, C.
    Venerito, V.
    Lapadula, G.
    Iannone, F.
    Cantarini, L.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2017, 35 (06) : S130 - S131
  • [6] LONG-TERM CLINICAL EFFICACY OF USTEKINUMAB IN REFRACTORY CROHN'S DISEASE: A MULTI-CENTRE BELGIAN COHORT STUDY
    Liefferinckx, Claire
    Verstockt, Bram
    Gils, Ann
    Noman, Maja
    Van Kemseke, Catherine
    Macken, Elisabeth
    De Vos, Martine
    Van Moerkercke, Wouter
    Rahier, Jean-Francois
    Bossuyt, Peter
    Dutre, Joris
    Humblet, Evelien
    Staessen, Dirk
    Peeters, Harald
    Van Hootegem, Philippe
    Louis, Edouard
    Franchimont, Denis
    Baert, Filip J.
    Vermeire, Severine
    GASTROENTEROLOGY, 2019, 156 (06) : S882 - S883
  • [7] Long-term clinical efficacy of ustekinumab in refractory Crohn's disease : a multi-centre Belgian cohort study
    Liefferinckx, C.
    Verstockt, B.
    Gils, A.
    Noman, M.
    Van Kemseke, C.
    Macken, E.
    De Vos, M.
    Van Moerkercke, W.
    Rahier, J. -F.
    Bossuyt, P.
    Dutre, J.
    Humblet, E.
    Staessen, D.
    Peters, H.
    Van Hootegem, P.
    Louis, E.
    Franchimont, D.
    Baert, F.
    Vermeire, S.
    JOURNAL OF CROHNS & COLITIS, 2019, 13 : S44 - S45
  • [8] Long-Term Clinical Effectiveness of Ustekinumab in Patients With Crohn's Disease: A Retrospective Cohort Study
    Ito, Takahiro
    Maemoto, Atsuo
    Katsurada, Takehiko
    Tanaka, Hiroki
    Motoya, Satoshi
    Ueno, Nobuhiro
    Fujiya, Mikihiro
    Ashida, Toshifumi
    Hirayama, Daisuke
    Nakase, Hiroshi
    CROHNS & COLITIS 360, 2020, 2 (04) : 1 - 9
  • [9] Real-world effectiveness and safety of ustekinumab for the treatment of refractory Crohn's disease: The Scottish ustekinumab cohort
    Plevris, N.
    Robertson, A.
    Fulforth, J.
    Hall, R.
    Campbell, I.
    Kane, C.
    Veryan, J.
    Lam, W.
    Saunders, J.
    Jenkinson, P.
    Chuah, C.
    Kelly, C.
    Watts, D.
    Gaya, D.
    Macdonald, J.
    Jafferbhoy, H.
    Seenan, J. P.
    Mowat, C.
    Sutherland, D.
    Naismith, G.
    Bain, G.
    Arnott, I.
    Jones, G.
    Lees, C.
    JOURNAL OF CROHNS & COLITIS, 2020, 14 : S484 - S484
  • [10] Long-term efficacy and safety of ustekinumab in refractory Crohn's disease patients: a multicenter retrospective experience
    Wils, P.
    Bouhnik, Y.
    Michetti, P.
    Flourie, B.
    Brixi, H.
    Bourrier, A.
    Allez, M.
    Duclos, B.
    Serrero, M.
    Buisson, A.
    Amiot, A.
    Fumery, M.
    Roblin, X.
    Peyrin-Biroulet, L.
    Filippi, J.
    Bouguen, G.
    Abitbol, V.
    Coffin, B.
    Simon, M.
    Laharie, D.
    Pariente, B.
    JOURNAL OF CROHNS & COLITIS, 2017, 11 : S43 - S43
12345